Aptus Pharma Ltd vs Desh Rakshak Aushdhalaya Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Aptus Pharma Ltd is ₹ 422.5 as of 05 May 15:30 . The P/E Ratio of Aptus Pharma Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Desh Rakshak Aushdhalaya Ltd changed from 4.5 on March 2021 to 29.5 on March 2025 . This represents a CAGR of 45.65% over 5 years The Market Cap of Aptus Pharma Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Desh Rakshak Aushdhalaya Ltd changed from ₹ 1.82 crore on March 2021 to ₹ 13.38 crore on March 2025 . This represents a CAGR of 49.03% over 5 years The revenue of Aptus Pharma Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Desh Rakshak Aushdhalaya Ltd for the Dec '25 is ₹ 1.4 crore as compare to the Sep '25 revenue of ₹ 0.95 crore. This represent the growth of 47.37% The ebitda of Aptus Pharma Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Desh Rakshak Aushdhalaya Ltd for the Dec '25 is ₹ 0.25 crore as compare to the Sep '25 ebitda of ₹ 0.26 crore. This represent the decline of -3.85% The net profit of Aptus Pharma Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Desh Rakshak Aushdhalaya Ltd changed from ₹ 0.09 crore to ₹ 0.09 crore over 7 quarters. This represents a CAGR of 0.00% The Dividend Payout of Aptus Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Desh Rakshak Aushdhalaya Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Aptus Pharma Ltd

Aptus Pharma Limited was originally incorporated as 'Aptus Pharma Private Limited', as a private limited company with the Registrar of Companies, Gujarat, pursuant to a Certificate of Incorporation dated August 12, 2010.
Subsequently, Company was converted into a public limited retaining the name as 'Aptus Pharma Limited' and a fresh certificate of incorporation dated December 12, 2024 was issued by the Registrar of Companies, Central Processing Centre. Company is engaged in the business of marketing, and distribution of finished pharmaceutical formulations.
While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model with 7 units. under various arrangements.
It provide a diverse range of pharmaceutical products catering to various therapeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products.

About Desh Rakshak Aushdhalaya Ltd

The flagship company Desh Rakshak Aushdhalaya Limited of Bhagwant Group was originally started in 1901 as a proprietoryship Concern by late Shri Bhagwant Rai Jain, a well renowned Vaidya Father of Late Dr. Paras Kumar Jain, Ex Chairman & Managing Director of the Company.
The Concern was converted into a Private Limited Company in Jul.'94. Desh Rakshakare the oldest manufacturer of Pure Ayurvedic and Herbal Products as discovered by the Ancient Seers & Sages.
The medicines are categorized into Proprietary & Classical Medicines.
They are currently manufacturing around 450 products (Proprietary & Classical mix) and all of these medicines are manufactured as per the prescribed norms and standards of the Indian Government.
The Company has been manufacturing ayurvedic medicines with traditional processes.

FAQs for the comparison of Aptus Pharma Ltd and Desh Rakshak Aushdhalaya Ltd

Which company has a larger market capitalization, Aptus Pharma Ltd or Desh Rakshak Aushdhalaya Ltd?

Market cap of Aptus Pharma Ltd is 280 Cr while Market cap of Desh Rakshak Aushdhalaya Ltd is 13 Cr

What are the key factors driving the stock performance of Aptus Pharma Ltd and Desh Rakshak Aushdhalaya Ltd?

The stock performance of Aptus Pharma Ltd and Desh Rakshak Aushdhalaya Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aptus Pharma Ltd and Desh Rakshak Aushdhalaya Ltd?

As of May 5, 2026, the Aptus Pharma Ltd stock price is INR ₹408.5. On the other hand, Desh Rakshak Aushdhalaya Ltd stock price is INR ₹23.62.

How do dividend payouts of Aptus Pharma Ltd and Desh Rakshak Aushdhalaya Ltd compare?

To compare the dividend payouts of Aptus Pharma Ltd and Desh Rakshak Aushdhalaya Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.